Introduction: medicine, politics, and governance -- Drug laws and therapeutic cultures -- Clinical trials from treatment to test, 1950-1980 -- Clinical trials as test and therapy, 1980-2000 -- Configuring the market as a testing site
Summary
Advocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials and monitoring systems in the US and Germany
Bibliography
Includes bibliographical references (pages 167-197) and index
